![Jen Jen Yeh speaks at a podium at the 2024 UNC Lineberger Scientific Symposium.](https://unclineberger.org/wp-content/uploads/sites/867/2024/06/1A4A4963-1-600x400.jpg)
June 28, 2024
Scientific symposium highlights latest developments in pancreatic cancer research
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
June 28, 2024
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
December 14, 2023
December 1, 2023
The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.
November 17, 2023
Researchers have learned more about an enzyme found to be overly expressed in patients with hereditary breast cancer, ovarian cancer and prostate cancer.
November 16, 2023
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
April 11, 2023
The AACR has elected Charles Perou, PhD, as a fellow to the AACR Academy. Members of this year’s class will be formally recognized at the AACR’s annual meeting.
April 10, 2023
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
March 17, 2023
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
January 19, 2023
UNC Lineberger's Ian Davis, MD, PhD, was awarded $1 million by the The V Foundation to support his work to improve CAR-T therapy for pediatric solid tumors.
January 9, 2023
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.